Announced Mon, 10 Aug, 2026 · 15:54 IST
CFO resigns, new CFO appointed; Q1 FY27 results approved
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reactionminutes from the announcement price · days from the prior close
—Next day
₹3.82
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used+0.2%—
Pharmaceuticals peers, median of 165sector-0.4%—
Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
—-0.2—+0.1—
Next day
—+0.2—-0.4—
2d
—+0.4—+0.1—
3d
-5.0+0.4-5.4-0.4-4.5
4d
-9.7+0.6-10.2-0.9-8.8
5d
-9.7+0.9-10.6-0.5-9.2
1w
-5.2+0.9-6.1-1.0-4.3
15d
-9.9+0.9-10.9-0.6-9.4
1m
-1.8+2.3-4.2+1.1-3.0
2m
—-1.1—-3.1—
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 165Pending
Minute windows have no benchmark: there is no intraday index history to compare against.
AI summary
CFO Mr. Swaraj Kumar Singh resigned due to pre-occupancy effective Aug 10, 2026. Ms. Roshni Poddar appointed as Whole-Time Director and CFO for 5 years. Q1 FY27 revenue rose to Rs 7.78 lakh from Rs 7.16 lakh, but net profit fell to Rs 0.65 lakh from Rs 1.28 lakh. AGM set for Sep 23, 2026.
Likely market impact
CFO transition may cause short-term disruption but is filled immediately. Q1 profit decline is a concern for shareholders.